A pertinent issue in the administration of pneumonic contaminations is the low explicitness of clinical side effects for the specific determination and the need of anti-infection treatment. A perfect biomarker for bacterial pneumonic diseases ought to permit a quick conclusion, have a prognostic esteem and encourage restorative dynamic.. The mix of a few biomarkers reflecting distinctive pathophysiological pathways can possibly improve the administration of network gained pneumonia later on.
Shebl, A., Sobieh, A., Elsayed, Y., & Mohamed, M. (2020). Copeptin as an Inflammatory Marker in Diagnosis and Prognosis of Community Acquired Pneumonia in Children. Benha Journal of Applied Sciences, 5(Issue 5 part (1)), 141-150. doi: 10.21608/bjas.2020.136639
MLA
A.S. Shebl; A.A. Sobieh; Y.I. Elsayed; M.R. Mohamed. "Copeptin as an Inflammatory Marker in Diagnosis and Prognosis of Community Acquired Pneumonia in Children", Benha Journal of Applied Sciences, 5, Issue 5 part (1), 2020, 141-150. doi: 10.21608/bjas.2020.136639
HARVARD
Shebl, A., Sobieh, A., Elsayed, Y., Mohamed, M. (2020). 'Copeptin as an Inflammatory Marker in Diagnosis and Prognosis of Community Acquired Pneumonia in Children', Benha Journal of Applied Sciences, 5(Issue 5 part (1)), pp. 141-150. doi: 10.21608/bjas.2020.136639
VANCOUVER
Shebl, A., Sobieh, A., Elsayed, Y., Mohamed, M. Copeptin as an Inflammatory Marker in Diagnosis and Prognosis of Community Acquired Pneumonia in Children. Benha Journal of Applied Sciences, 2020; 5(Issue 5 part (1)): 141-150. doi: 10.21608/bjas.2020.136639
)
View on SCiNiTO